Clinical Trial Information

BioSET Prefix Study

Study Details

This study is designed to evaluate the safety and preliminary effectiveness of one coating concentration of Prefix compared to iliac crest bone in approximately 22 skeletally mature subjects diagnosed with degenerative disc disease (DDD) at one vertebral level (L2-S1).

Primary Sponsor:

Biosurface Engineering Technologies, Inc. (BioSET)

Prinicipal Investigator:

Joseph O'Brien MD

Interested in More Information

First Name

Please enter your first name.
Last Name

Please enter your last name.
Email:

This isn't a valid email address.

Please enter your email address.
Phone

This isn't a valid phone number.

Please enter your phone number.

You entered an invalid number.
Address

Please enter your address.
City

Please enter your city.
Select State

Please enter your state.
Zip Code

Please enter your zip code.
Verification Code * (All Uppercase. No Spaces)